October 2014
Hyris Ltd founded in London, UK
July 2015
R&D facilities open in Milan, Italy
January 2016
The HYRIS bCUBE™ 1.0 completes the first successful run.
April 2016
First client orders are booked, third-party integration activities start.
May 2016
Key customer demos and technical co-development.
First commercial revenues are booked.
October 2016
Hyris obtains the Seal of Excellence of the European Commission.
May 2017
Hyris announces partnership and entry into the Botanicals application area.
August 2017
HYRIS bCUBE™ 2.0 is available for sale.
April 2019
Hyris launches its product line for Probiotics strains identification.
April 2020
Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.
June 2020
Hyris receives Series-A funding.
September 2020
Entrance in the healthcare sector, with CE-IVD marking and Health Canada approval for SARS-CoV-2 human specimend test.
September 2021
Hyris presents its new Brand Identity, supporting its fast growth worldwide.
November 2021
HYRIS bCUBE 3™ is available for sale.
December 2021
Hyris obtains ISO9001 and ISO13485 certifications.
February 2022
Hyris obtains IS27001 certification.
September 2022
First marketplace applications in product catalog.
October 2014
Hyris Ltd founded in London, UK
July 2015
R&D facilities open in Milan, Italy
January 2016
The HYRIS bCUBE™ 1.0 completes the first successful run.
April 2016
First client orders are booked, third-party integration activities start.
May 2016
Key customer demos and technical co-development.
First commercial revenues are booked.
October 2016
Hyris obtains the Seal of Excellence of the European Commission.
May 2017
Hyris announces partnership and entry into the Botanicals application area.
August 2017
HYRIS bCUBE™ 2.0 is available for sale.
April 2019
Hyris launches its product line for Probiotics strains identification.
April 2020
Hyris launches its test for the identification of the SARS-CoV-2 on environmental surfaces.
June 2020
Hyris receives Series-A funding.
September 2020
Entrance in the healthcare sector, with CE-IVD marking and Health Canada approval for SARS-CoV-2 human specimend test.
September 2021
Hyris presents its new Brand Identity, supporting its fast growth worldwide.
November 2021
HYRIS bCUBE 3™ is available for sale.
December 2021
Hyris obtains ISO9001 and ISO13485 certifications.
February 2022
Hyris obtains IS27001 certification.